up home page bottom

French German version Spanish version Italian version

header image

Merck Puts Some of Their Gardasil Cash To Work

Merck to buy Schering-Plough in $41 billion deal Reported by David Jolly Publ With the purchase, Merck is expanding its franchise in cardiovascular, respiratory and oncology drugs and shoring up its research pipeline, in particular with a Schering-Plough product called TRA, a promising drug designed to prevent blood  clotting. In addition, Merck will benefit from the [...]

Share

Merck Execs See ‘Sage’ as Key Ingredient for Disease Biology

Will Open Source “SAGE” platform lead to more transperency to MERCK’s research and clinical trials process? Consumers can only  hope. Of course if  MERCK corporate lawyers figure out that such an open source platform may lead to a clear chain of custody of the type of information they would rather not have readily available during [...]

Share

Social Networking Sites Have Myriad Trial-Related Uses

The information in this post was gathered from an article published by Deb Bortifz in eCliniqua, Innovative Management in Clinical Trials. eCliniqua offers PodCasts, WebCasts, White Papers and much more. Their ‘data-rich’ site is one of my primary research resources for an objective review of clinical trial process and results. March 2, 2009 | A [...]

Share

NVIC Says Government Denies Gardasil Risks

Vaccine Watchdog Group Calls for Transparency WASHINGTON–(BUSINESS WIRE)–The National Vaccine Information Center (NVIC) is calling on the Centers for Disease Control (CDC) and Food and Drug Administration (FDA) to publicly release the study design, data and names of principal investigators involved in a statement this week maintaining that Gardasil vaccine is safe with no serious [...]

Share

Supreme Court To Consider Federal Pre-Emption In Wyeth V. Levine

The U.S. Supreme Court next week will begin hearing the case of Wyeth v. Levine, which centers on the question of whether FDA approval of a drug warning label pre-empts product safety suits brought in state courts, the Wall Street Journal reports (Mundy/Wang, Wall Street Journal, 10/27). The case involves Diana Levine, who lost her [...]

Share

FDA Addresses Questions About Gardasil®

Those of you who are regular readers know that I think Gardasil® is the wrong solution for preventing Cervical Cancer. It is my considered opinion that Gardasil® has one purpose — it is a much needed cash cow for Merck, in their time of financial need.  My attempt at “Fair and Balanced” reporting is to [...]

Share

Gardasil — When Mercketing Pre-empts Medicine

It is not hard to hear about Gardasil… “In television advertisements, a cast of hip people in their 20s — artists, writers and professionals — describe why they got the shots, in the language of liberation, such as, “I chose to get vaccinated because my dreams don’t include cervical cancer.” The advertisements direct viewers to [...]

Share